Whitehawk Therapeutics Management
Management criteria checks 3/4
Whitehawk Therapeutics' CEO is Dave Lennon, appointed in Oct 2023, has a tenure of 1.42 years. total yearly compensation is $1.01M, comprised of 64.7% salary and 35.3% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €58.68K. The average tenure of the management team and the board of directors is 2.3 years and 3.6 years respectively.
Key information
Dave Lennon
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 64.7% |
| CEO tenure | 1.4yrs |
| CEO ownership | 0.1% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | US$1m | US$654k | -US$64m |
| Sep 30 2024 | n/a | n/a | -US$62m |
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$69m |
| Dec 31 2023 | US$2m | US$160k | -US$66m |
Compensation vs Market: Dave's total compensation ($USD1.01M) is above average for companies of similar size in the German market ($USD482.62K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Lennon (53 yo)
1.4yrs
Tenure
US$1,012,068
Compensation
Dr. David J. Lennon, Ph.D. also known as Dave, is the Treasurer at Alliance for Regenerative Medicine from April, 2022. He is the CEO of Satellite Bio. He serves as President and CEO & Director at Whitehaw...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.4yrs | US$1.01m | 0.14% € 58.7k | |
| Founder & Director | 13.4yrs | US$1.66m | 7.35% € 3.2m | |
| CFO, Treasurer | 3.3yrs | US$807.93k | 0.097% € 42.0k | |
| Chief Technical Operations Officer | 1yr | US$648.57k | 0.82% € 356.1k | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Senior VP of Legal & General Counsel | 3.1yrs | no data | no data |
2.3yrs
Average Tenure
53yo
Average Age
Experienced Management: 3350's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.4yrs | US$1.01m | 0.14% € 58.7k | |
| Founder & Director | 13.4yrs | US$1.66m | 7.35% € 3.2m | |
| Independent Chairman of the Board | 3.6yrs | US$138.00k | 0.080% € 34.6k | |
| Independent Director | 3.5yrs | US$118.00k | 0% € 0 | |
| Independent Director | 3.6yrs | US$113.00k | 0.0046% € 2.0k | |
| Independent Director | 3.6yrs | US$102.50k | 0.0043% € 1.9k | |
| Independent Director | 8.1yrs | US$118.00k | 0% € 0 | |
| Independent Director | 2yrs | US$98.00k | 0% € 0 | |
| Independent Director | 3.6yrs | US$102.50k | 0% € 0 | |
| Independent Director | less than a year | US$107.43k | 5.07% € 2.2m |
3.6yrs
Average Tenure
53yo
Average Age
Experienced Board: 3350's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/28 00:49 |
| End of Day Share Price | 2025/03/28 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Whitehawk Therapeutics, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Burns | H.C. Wainwright & Co. |
| Roger Song | Jefferies LLC |
| Boris Peaker | TD Cowen |